NeuroMetrix, Inc. (NURO)

4.3900 +0.7600 (+20.82%) As of 03:23PM EDT. Market open.

NeuroMetrix, Inc.

4B Gill Street
Woburn, MA 01801
United States
781 890 9989
https://www.neurometrix.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 26

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Shai N. Gozani M.D., Ph.D.	Founder, Chairman, CEO, President & Secretary	444.05k	N/A	1965
Mr. Thomas T. Higgins	Senior VP, CFO & Treasurer	347.75k	N/A	1952
Dr. Xuan Kong Ph.D.	Chief Data Scientist	N/A	N/A	N/A
Ms. Susan M. Bell R.N.	Senior Vice President of Population Health & Value Based Care	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.

Corporate governance

NeuroMetrix, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.